Article info

Download PDFPDF

Tofacitinib in refractory adult-onset Still’s disease: 14 cases from a single centre in China

Authors

  1. Correspondence to Chengde Yang, Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; yangchengde{at}sina.com; Dr Hui Shi; shihui_sjtu{at}sina.com
View Full Text

Citation

Hu Q, Wang M, Jia J, et al
Tofacitinib in refractory adult-onset Still’s disease: 14 cases from a single centre in China

Publication history

  • Received November 24, 2019
  • Revised February 4, 2020
  • Accepted February 5, 2020
  • First published February 20, 2020.
Online issue publication 
May 20, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.